Does personalised risk communication increase consumers’ uptake of screening tests?
Providing risk information in ways that better inform people may sometimes lead to participation rates in screening, eg. PSA testing in men (these studies largely involved white American men attending single clinics).¹ 1. Barry MJ. Ann Intern Med 2002;136:127-135.
People considering participation in screening may receive information about the general risk of having the disease or condition, or information that is tailored to their personal risk status (personalised risk information). Personalised risk information involves calculating an individual’s risk factors using formulae derived from epidemiological data, and presented as an absolute or relative risk score, or categorising them into high, medium or low risk groups.